Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
460-03-002 ISMRM Abstract

Linking MRI Morphology to Prognosis Across Breast Cancer Subtypes

Primary: Body - Breast
Secondary: Analysis Methods - Classification and Prediction
460-03-002 · Image Classification for Breast Cancer · Tuesday, 12 May, 1:40 PM–2:35 PM · Digital Posters Row A
Keywords: Disease-free survival Breast Imaging Luminal breast cancer HER2-positive breast cancer
Accepted
Carla C Tajima1, Soraia Q Damião1, Thais Bezerra 2, Almir G Bitencourt1
1A C Camargo Cancer Center, Sao Paolo, Brazil
2University of Campinas, Campinas, Brazil
Presenting Author: Thais Bezerra

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Waks AG, Winer EP. Breast Cancer Treatment: A Review. JAMA. 2019;321(3):288-300.
2. Dontchos BN, Phelps MD, Rahbar H, Lam DL. Pre-Treatment Breast MRI: Clinical Indications, Outcomes, and Future Directions. J Magn Reson Imaging. 2025 Aug;62(2):346-361.
3. Cho N, Moon WK, Han W, et al. Breast cancer subtypes: MR imaging and histopathologic correlation. Eur Radiol. 2012;22(1):18-25.
4. Tajima CC, Arruda FPSG, Mineli VC, et al. MRI features of breast cancer immunophenotypes with a focus on luminal estrogen receptor low positive invasive carcinomas. Sci Rep. 2024;14(1):19305.
5. Ab Mumin N, Ramli Hamid MT, Wong JHD, Rahmat K, Ng KH. Magnetic Resonance Imaging Phenotypes of Breast Cancer Molecular Subtypes: A Systematic Review. Acad Radiol. 2022;29 Suppl 1:S89-S106.
6. Wolff AC, Somerfield MR, Dowsett M, et al. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline Update. J Clin Oncol. 2023;41(22):3867-3872.
7. Allison KH, Hammond MEH, Dowsett M, et al. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update. J Clin Oncol. 2020;38(12):1346-1366.
8. Müller M, Baltzer PAT, Dietzel M. Clinical imaging of the heterogeneous group of triple-negative breast cancer. Clin Imaging. 2022;83:168-75.
9. Dogra A, Srivastava A, Jain M, et al. Androgen receptor expression in triple-negative breast cancer: a report from a tertiary care center. Breast Dis. 2020;39(3):145-50.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/460-03-002